Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (261-270 of 325) with videos related to

Pageof 33
Sort By:
Open Forum Infectious Diseases|January 8, 2020
Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles CountyMoses J E Flash, Wendy H Garland, Emily B Martey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2016
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
Open Forum Infectious Diseases|July 24, 2019
Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency VirusSophie Desmonde, Simone C Frank, Ashraf Coovadia, et al.
AIDS (London, England)|September 28, 2016
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participantsPranab K Mukherjee, Huichao Chen, Lauren L Patton, et al.
Journal of the International AIDS Society|January 5, 2023
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settingsCaitlin M Dugdale, Ogochukwu Ufio, Christopher Alba, et al.
Implementation Science Communications|June 24, 2024
Using simulation modeling to inform intervention and implementation selection in a rapid stakeholder-engaged hybrid effectiveness-implementation randomized trialJessica E Becker, Fatma M Shebl, Elena Losina, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Journal of the International AIDS Society|April 1, 2018
The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in BrazilPaula M Luz, Benjamin Osher, Beatriz Grinsztejn, et al.
Open Forum Infectious Diseases|January 14, 2022
Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South AfricaTijana Stanic, Nicole McCann, Martina Penazzato, et al.
Pageof 33

Showing results (261-270 of 325) with videos related to

Sort By:
Pageof 33
Open Forum Infectious Diseases|January 8, 2020
Cost-effectiveness of a Medical Care Coordination Program for People With HIV in Los Angeles CountyMoses J E Flash, Wendy H Garland, Emily B Martey, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2016
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2009
Racial and sex disparities in life expectancy losses among HIV-infected persons in the united states: impact of risk behavior, late initiation, and early discontinuation of antiretroviral therapyElena Losina, Bruce R Schackman, Sara N Sadownik, et al.
Open Forum Infectious Diseases|July 24, 2019
Cost-Effectiveness of Preemptive Switching to Efavirenz-Based Antiretroviral Therapy for Children With Human Immunodeficiency VirusSophie Desmonde, Simone C Frank, Ashraf Coovadia, et al.
AIDS (London, England)|September 28, 2016
Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participantsPranab K Mukherjee, Huichao Chen, Lauren L Patton, et al.
Journal of the International AIDS Society|January 5, 2023
Cost-effectiveness of broadly neutralizing antibody prophylaxis for HIV-exposed infants in sub-Saharan African settingsCaitlin M Dugdale, Ogochukwu Ufio, Christopher Alba, et al.
Implementation Science Communications|June 24, 2024
Using simulation modeling to inform intervention and implementation selection in a rapid stakeholder-engaged hybrid effectiveness-implementation randomized trialJessica E Becker, Fatma M Shebl, Elena Losina, et al.
HIV Clinical Trials|December 15, 2015
Prioritizing HIV comparative effectiveness trials based on value of information: generic versus brand-name ART in the USPamela P Pei, Milton C Weinstein, X Cynthia Li, et al.
Journal of the International AIDS Society|April 1, 2018
The cost-effectiveness of HIV pre-exposure prophylaxis in men who have sex with men and transgender women at high risk of HIV infection in BrazilPaula M Luz, Benjamin Osher, Beatriz Grinsztejn, et al.
Open Forum Infectious Diseases|January 14, 2022
Cost-effectiveness of Routine Provider-Initiated Testing and Counseling for Children With Undiagnosed HIV in South AfricaTijana Stanic, Nicole McCann, Martina Penazzato, et al.
Pageof 33